Meropenem & Sulbactam For Inj.

What is Meropenem & Sulbactam For Injection?

Meropenem & Sulbactam For Injection is a combination antibacterial product listing meropenem, a carbapenem antibiotic, and sulbactam, a beta-lactamase inhibitor with antibacterial activity against certain organisms. The clinical role and appropriate use of this combination depend on its confirmed formulation, approved product information and the susceptibility of the causative bacteria.

Uses / Indications

The potential use of this combination must be confirmed against the approved product information for the exact formulation. Meropenem-containing products may be used by healthcare professionals to treat certain serious bacterial infections caused by susceptible organisms.

• Treatment decisions should be based on the suspected or confirmed infection and relevant microbiology results.

• Use should follow applicable local prescribing guidance and approved indications.

• It is not intended to treat viral infections such as colds or influenza.

Benefits

• Combines meropenem with sulbactam in a single listed formulation.

• Meropenem provides antibacterial activity against a range of susceptible bacteria.

• Sulbactam may inhibit certain beta-lactamase enzymes; its contribution depends on the organism and the confirmed formulation.

• The listed 1.5 g presentation may support product-sourcing requirements, subject to specification confirmation.

Side Effects

Potential side effects depend on the confirmed formulation, dose, patient characteristics and clinical circumstances.

Common side effects

• Nausea or vomiting.

• Diarrhoea.

• Headache.

• Rash or itching.

• Injection-site reactions.

Less common or serious side effects

• Severe allergic reactions, including anaphylaxis.

• Seizures or other neurological reactions.

• Severe or persistent antibiotic-associated diarrhoea.

• Changes in blood-cell counts or liver-function test results.

Seek urgent medical attention for breathing difficulty, facial or throat swelling, severe skin reactions or seizures.

How Does It Work?

Meropenem inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins, disrupting cell-wall formation in susceptible bacteria. Sulbactam inhibits certain beta-lactamase enzymes that can inactivate some beta-lactam antibiotics and also has intrinsic activity against selected organisms. The clinical effectiveness of this particular combination must be established from its approved formulation and product information.

Dosage Guidelines

Dosage depends on the confirmed component strengths, infection type and severity, patient age, renal function and the susceptibility of the causative organism.

• Administration must be supervised by qualified healthcare professionals.

• Renal-function assessment and dose adjustment may be necessary.

• Reconstitution, dilution, compatibility and administration must follow the approved product instructions.

• Do not infer individual ingredient quantities from the stated total strength of 1.5 g.

The exact dose, administration route, frequency and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

Use may be inappropriate in patients with:

• Known serious hypersensitivity to meropenem, sulbactam or any formulation component.

• A history of severe allergic reactions to beta-lactam antibiotics, unless a qualified healthcare professional determines that use is appropriate under the approved product information.

The patient’s allergy history and clinical condition should be assessed before treatment.

Drug / Product Interactions

Potentially important interactions include:

• Valproic acid or divalproex: Meropenem can markedly reduce valproate concentrations and increase seizure risk. This combination is generally not recommended.

• Probenecid: May affect meropenem elimination and increase exposure.

• Medicines affecting kidney function or seizure risk: A professional review may be required.

• Other intravenous medicines: Compatibility must be confirmed before mixing or co-administration.

The complete medication list should be reviewed by a qualified healthcare professional.

Safety Advice

• Use only when clinically indicated for a susceptible bacterial infection.

• Confirm the formulation and individual component strengths before use.

• Check the patient’s allergy history.

• Monitor for allergic reactions, neurological symptoms and severe diarrhoea.

• Follow appropriate antimicrobial stewardship practices to help limit antibiotic resistance.

General Instructions

• Verify the product name, strength, vial integrity and expiry date before use.

• Confirm whether WFI is supplied and follow the approved preparation instructions.

• Prepare and administer using appropriate aseptic procedures.

• Do not use damaged or compromised packaging.

• Do not mix with other medicines unless compatibility is established by the approved product information.

Special Dietary / Lifestyle Tips

No universal special diet is established for this product. Patients should follow their healthcare professional’s advice regarding hydration, dietary restrictions and recovery during treatment. Any diet or fluid limitations associated with an existing medical condition should be respected.

Comparison with Other Treatments

Meropenem is a carbapenem antibiotic, while sulbactam is a beta-lactamase inhibitor with activity against selected organisms. Other antibiotic combinations may have different spectra of activity, approved indications and resistance profiles. Treatment selection should be based on the confirmed product formulation, infection site, microbiology results, patient-specific factors and local clinical guidance.

Precautions & Warnings

• Allergy risk: Serious hypersensitivity reactions may occur.

• Renal impairment: Dose adjustment may be needed.

• Seizure risk: Use caution in patients with seizure disorders or other neurological risk factors.

• Antimicrobial resistance: Unnecessary or inappropriate use may contribute to resistance.

• Pregnancy and breastfeeding: Use requires an individual clinical risk-benefit assessment.

• Paediatric use: Dosing and suitability depend on age, weight, infection and approved product information.

• Formulation verification: Confirm the component quantities and approved status of the specific combination before relying on general information about meropenem or sulbactam.

Can I Use It With Other Medicines?

Generally Compatible With

Other medicines may be used alongside this product when clinically indicated, following a professional interaction review and the approved product instructions.

Use With Caution

• Medicines that may affect kidney function.

• Medicines that may increase seizure risk.

• Other antibiotics or intravenous medicines requiring compatibility assessment.

Avoid

• Concomitant use with valproic acid or divalproex is generally not recommended because meropenem can markedly reduce valproate concentrations.

• Do not mix with other medicines in the same container or infusion line unless compatibility has been confirmed.

Storage

Store according to the specific product label and approved product information. Storage requirements may differ between unopened vials and prepared solutions. Do not assume a storage temperature, light-protection requirement or in-use period without the approved instructions.

Frequently Asked Questions

1. What is Meropenem & Sulbactam For Injection used for?

Its intended use depends on the approved indications for the exact combination. Meropenem is used for certain susceptible bacterial infections under medical supervision.

2. What is the strength of this product?

The supplied product details list a total strength of 1.5 g. The individual quantities of meropenem and sulbactam require confirmation.

3. Is meropenem a carbapenem antibiotic?

Yes. Meropenem belongs to the carbapenem subclass of beta-lactam antibiotics.

4. What is the role of sulbactam?

Sulbactam inhibits certain beta-lactamase enzymes and has antibacterial activity against selected organisms. Its contribution to this specific combination depends on the confirmed formulation.

5. Does the vial include Water for Injection?

The supplied description states “Vial With WFI”. Confirm whether WFI is included with the presentation and verify the approved preparation instructions.

6. Can this product be used for viral infections?

No. Antibiotics do not treat viral infections such as the common cold or influenza.

7. Can it be used with valproate?

Meropenem can substantially reduce valproate concentrations and increase seizure risk. The combination is generally not recommended; treatment alternatives should be assessed by the treating healthcare professional.

8. How can international buyers enquire about this product?

Buyers can contact Kelar Pharmachem India to enquire about sourcing, packing options and available product documentation, subject to confirmation and availability.